<bill session="118" type="s" number="2157" updated="2024-07-24T15:21:28Z">
  <state datetime="2023-06-22">REFERRED</state>
  <status>
    <introduced datetime="2023-06-22"/>
  </status>
  <introduced datetime="2023-06-22"/>
  <titles>
    <title type="display">Protect Drug Innovation Act</title>
    <title type="short" as="introduced">Protect Drug Innovation Act</title>
    <title type="official" as="introduced">A bill to repeal prescription drug price control provisions of the Inflation Reduction Act.</title>
  </titles>
  <sponsor bioguide_id="L000577"/>
  <cosponsors>
    <cosponsor bioguide_id="R000595" joined="2023-06-22"/>
  </cosponsors>
  <actions>
    <action datetime="2023-06-22">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2023-06-22" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2024-07-19T20:52:32Z" status="Introduced in Senate">Protect Drug Innovation Act

This bill repeals several programs and requirements that were enacted under the Inflation Reduction Act of 2022 relating to the prices of prescription drugs, including (1) the Medicare Drug Price Negotiation Program, (2) provisions that require drug manufacturers to issue rebates for certain drugs under Medicare for which prices increase faster than inflation, and (3) provisions that cap annual out-of-pocket spending under the Medicare prescription drug benefit.</summary>
</bill>
